Coping Skills and Physical Activity for Lung Transplant Recovery
(INSPIRE-III Trial)
Trial Summary
What is the purpose of this trial?
This study evaluates the effectiveness of a coping skills and exercise (CSTEX) intervention among post lung transplant patients aimed to reduce distress and improve functional capacity. Half of the patients will receive CSTEX and half will receive the standard of care plus transplant education (SOC-ED).
Do I need to stop my current medications for the trial?
The trial does not specify if you need to stop your current medications, but it mentions that participants should be on a stable medication regimen. This suggests you may continue your current medications as long as they are stable.
What data supports the effectiveness of the treatment Coping Skills Training combined with Exercise (CSTEX) for lung transplant recovery?
Exercise training has been shown to improve exercise capacity and quality of life in lung transplant patients, and strategies to increase physical activity and reduce emotional distress are needed to enhance recovery. While direct evidence for CSTEX is limited, exercise and coping skills are beneficial components for improving outcomes in lung transplant recipients.12345
Is the combination of coping skills training and exercise safe for lung transplant recovery?
How does the CSTEX treatment differ from other treatments for lung transplant recovery?
The CSTEX treatment is unique because it combines coping skills training with exercise to address both emotional distress and physical inactivity, which are common issues after lung transplantation. This dual approach aims to improve quality of life and functional capacity, unlike standard treatments that may focus solely on medical management or physical rehabilitation.12347
Eligibility Criteria
This trial is for individuals who are at least 6 weeks post-lung transplant, on stable medications, completed pulmonary rehab in the last 18 months, and speak English. It's not for pregnant women, those unable to consent, multi-organ or repeat lung recipients, or with a life expectancy under 12 months due to other illnesses.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either CSTEX or SOC-ED intervention consisting of 12 weekly sessions
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Coping Skills Training combined with Exercise (CSTEX)
- Standard of Care plus Education (SOC-ED)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor